USPTO serial 99918701
PRELI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWEENEY, MOLLY B
- Law office
- TMO LAW OFFICE 121
What this means
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
Need help with PRELI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan R. Bradshaw
Megan R. Bradshaw Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for human use, namely, pharmaceutical preparations for endometrial health purposes; Pharmaceutical products for treating disorders and disturbances of the endometrium; Clinical diagnostic test kits for testing biopsy and other tissue samples for use in detecting disorders of the endometrium consisting primarily of medical diagnostic reagents; Diagnostic agents, for medical use; Diagnostic preparations, for medical purposes; Clinical diagnostic reagents for medical use; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis and decidual reaction analysis; Diagnostic test kits for medical purposes consisting primarily of medical diagnostic reagents; In vitro diagnostic preparations for medical purposes; Indicators in the nature of protein arrays for medical diagnosis | ACTIVE | — |
| 042 | Laboratory testing of materials; Laboratory services for the production of pharmaceuticals; Research laboratory analysis services in the field of gynecology, obstetrics, and reproductive endocrinology and infertility (REI); Analytical laboratories, namely, scientific laboratory services; Chemical laboratories; Laboratory research services relating to pharmaceuticals; Scientific laboratory services; Biological research laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 4, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 2, 2026 | NWAP | NEW APPLICATION ENTERED | — |